APOA1 and metabolic syndrome: The nonHDLc to HDLc ratio (nonHDLc/HDLc ratio) could indicate combined lipid problems and was demonstrated as a better predictor for multiple dyslipidemia-related disorders, such as coronary heart disease (CHD) [13], insulin resistance, metabolic syndrome and chronic kidney disease than single lipoprotein or the apoB/apoA1 ratio [14].